Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (101-110 of 339) with videos related to

Pageof 34
Sort By:
American Journal of Hematology|April 25, 2017
Early mortality and overall survival of acute myeloid leukemia based on facility typeVijaya R Bhatt, Valerie Shostrom, Smith Giri, et al.
Haematologica|March 12, 2011
Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot studyRoland B Walter, Stephanie J Lee, Kelda M Gardner, et al.
Haematologica|July 18, 2012
Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemiaPamela S Becker, Hagop M Kantarjian, Frederick R Appelbaum, et al.
Blood Neoplasia|August 12, 2025
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapySuravi Raychaudhuri, Megan Othus, Mary-Elizabeth M Percival, et al.
Haematologica|July 14, 2022
Improved outcomes with "7+3" induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial dataMegan Othus, Guillermo Garcia-Manero, John E Godwin, et al.
Epigenetics|May 22, 2015
Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemiaXiaoyu Qu, Jerry Davison, Liping Du, et al.
Haematologica|March 22, 2015
Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemiaDaisuke Araki, Megan Othus, Roland B Walter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantationDerek L Stirewalt, Katherine A Guthrie, Lan Beppu, et al.
Blood|October 8, 2008
Thyroid function following hematopoietic cell transplantation in children: 30 years' experienceJean E Sanders, Paul A Hoffmeister, Ann E Woolfrey, et al.
Leukemia|December 12, 2024
Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemiaCorentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí, et al.
Pageof 34

Showing results (101-110 of 339) with videos related to

Sort By:
Pageof 34
American Journal of Hematology|April 25, 2017
Early mortality and overall survival of acute myeloid leukemia based on facility typeVijaya R Bhatt, Valerie Shostrom, Smith Giri, et al.
Haematologica|March 12, 2011
Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot studyRoland B Walter, Stephanie J Lee, Kelda M Gardner, et al.
Haematologica|July 18, 2012
Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemiaPamela S Becker, Hagop M Kantarjian, Frederick R Appelbaum, et al.
Blood Neoplasia|August 12, 2025
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapySuravi Raychaudhuri, Megan Othus, Mary-Elizabeth M Percival, et al.
Haematologica|July 14, 2022
Improved outcomes with "7+3" induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial dataMegan Othus, Guillermo Garcia-Manero, John E Godwin, et al.
Epigenetics|May 22, 2015
Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemiaXiaoyu Qu, Jerry Davison, Liping Du, et al.
Haematologica|March 22, 2015
Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemiaDaisuke Araki, Megan Othus, Roland B Walter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantationDerek L Stirewalt, Katherine A Guthrie, Lan Beppu, et al.
Blood|October 8, 2008
Thyroid function following hematopoietic cell transplantation in children: 30 years' experienceJean E Sanders, Paul A Hoffmeister, Ann E Woolfrey, et al.
Leukemia|December 12, 2024
Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemiaCorentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí, et al.
Pageof 34